Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protein SPO16 homolog (SPO16) is an evolutionarily conserved protein with an XPF-like domain, functioning as a key regulator of meiotic crossover formation and synaptonemal complex stability[1][2][4]. SPO16 forms a heterodimeric complex with SHOC1, analogous to the ERCC4:XPF family, that binds to specific DNA structures during recombination[1][2]. SPO16 localizes to the chromosome axes during meiotic prophase I and is essential for proper crossover formation and chromosome synapsis. Deletion of SPO16 leads to defective homologous pairing, incomplete synapsis, and infertility, though other aspects of organismal health are not affected[2]. Disease relevance is primarily in the context of germ cell development, with no formal role as a drug target or biomarker described in humans. Frequently studied in conjunction with other meiotic proteins (e.g., TEX11, SHOC1, MSH4, MSH5), SPO16 helps reinforce the integrity of the synaptonemal complex, ensuring successful progression of meiosis[1][2][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein SPO16 homolog (SPO16).